Dang, Nam H. and Ogura, Michinori and Castaigne, Sylvie and Fayad, Luis E. and Jerkeman, Mats and Radford, John and Antonio, Antonio and Bondarenko, Igor and Stewart, Douglas A and Shnaidman, Michael and Sullivan, DR. Sharon and Vandendries, Erik and Tobinai, Kensei and Ramchandren, Radhakrishnan and Hamlin, Paul A. and Giné, Eva and Ando, Kiyoshi (2018) Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/ refractory aggressive B-cell non-Hodgkin lymphoma. British Journal of Haematology, 182 (4). pp. 583-586. ISSN 1365-2141
|
Text
nihms-945024.pdf Download (54kB) | Preview |
Official URL: https://doi.org/10.1111/bjh.14820
| Item Type: | Article |
|---|---|
| Additional Information: | https://doi.org/10.1111/bjh.14820 |
| Uncontrolled Keywords: | inotuzumab ozogamicin; B-cell non-Hodgkin lymphoma; CD22+; antibody-drug conjugate; rituximab |
| Subjects: | Oncology |
| Divisions: | Departments > Department of Oncology and Medical Radiology |
| Depositing User: | Елена Шрамко |
| Date Deposited: | 28 Apr 2020 15:56 |
| Last Modified: | 28 Apr 2020 15:56 |
| URI: | http://repo.dma.dp.ua/id/eprint/5292 |
Actions (login required)
 |
View Item |
